Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 294 participants.

Also called NCT04161170

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 294 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04161170
Other papers using this trial's data
  • An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial Diabetes care, 2023-05-01 DOI, PubMed 36821833

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04161170. Randomized; no masking; primary purpose treatment. Start 2019-11-20 (actual); primary completion 2021-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes
Intervention (Device)
Digital integrated healthcare platform
Lead sponsor
Samsung Medical Center (class: other)

Record details

Record id
cardio:ct-nct04161170
Content hash
73c0a8c7917294f744a78f37b0d9802c9f5432658d79ffd30d8335fad5c6b7ec